|Categories of Angiotrofin||Other|
|Average price (USD)||$0.48 Diltiazem|
|Manufacturer country (Worldwide Sale)||Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama|
|Medication Class||Calcium channel blocking agents|
Diltiazem is a CYP3A4 substrate and enzalutamide is a strong CYP3A4 allow. When Angiotrofin is given to individuals with heart failure, symptoms of heart failure may worsen because these drugs reduce the ability of the heart to pump blood. After 24 months, survival was similar in the diltiazem and placebo groups.
Possible side effects of Angiotrofin include:
Angiotrofin is used to treat diseases such as: Angina Pectoris Prophylaxis, Atrial Fibrillation, Atrial Flutter, Heart Failure, High Blood Pressure, Raynaud's Syndrome, Supraventricular Tachycardia.
Dosage in patients with normal renal function.